Optimizing Tobacco Treatment Delivery for People Living with HIV

Sponsor:

National Cancer Institute

Sponsor Study ID:

R01 CA261232-01

CTO #:

103383

NCT Number:

NCT05019495

Phase:

N/A

Protocol Type:

Health Services Research

Age Group:

Adults

Disease Sites:

Study Objectives:

To conduct a randomized clinical trial with PLWH who smoke (N=230) comparing smoking cessation outcomes consistent with the RFA including: biochemically verified 7-day point prevalence abstinence (PPA) rates, continuous abstinence (Weeks 9-12), and the number of 24-hour quit attempts at the end of study treatment (Week 12) between participants who receive TAU and PrOMOTE.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)